PZL TELL ME SESA GOA CALL340 GOOD OR BAD ?

View Profile

Thanx Krishnaji for your support... :)

View Profile

From : Ashish Pradhan at 09:42 PM - Jul 15, 2010 (14 minutes ago)

As per option and future data ,this stock is weak..may go 320 then 300 ..(but i think it will get support at 300and then consolidate )

View Profile

As per option and future data ,this stock is weak..may go 320 then 300 ..(but i think it will get support at 300and then consolidate )

View Profile

it is a good. keep 338 spot as strict sl.

View Profile

Hummmm .......Good points....Let me analyse once more wit keeping these datas tooo .......Newayz Very Thank You BM.

View Profile

Krishna........... that's a very Good Research with backing of Data ............ but do you know in Oct 2008 - March 2009 Lows Sensex was trading @ 11 - 13 P/E ............. in Short to Medium Term Stocks Trade at Weird P/E ........... but anyways now Why Sesa Goa is'nt looking good...... Technicals are'nt Supporting it ...News coming for Iron Ore Sector is'nt Positive from the Government side..... Duty is going to be increased , limit is going to be layed on Quantity of Iron Ore Export ....another thing Sesa Goa is the biggest Exporter of Iron Ore to China..... China's GDP nos. were Below Expectation ...suggesting China is slowing Down faster than the Government intended it to slow down does that Effects Sesa Goa's Business.................Thus Putting UNCERTAINTY over the Sesa Goa's Business & Earnings...... all these will play their part on the Stock Price in Short Run.................. Hope i have answered your query now.................

View Profile

Others view on this stock will be welcomed. Plz share ur views.

View Profile

it might first come down in day or two.

View Profile

Well one of the very few undervalued but very potential stock present in the market at the current levels. If you cn hold this stock for 6-8 months thn this will give u very gud returns. Lets see below y I m saying this....

COURTESY- Value Reasearch

Screening Criteria
In our list, we have included companies that have average return on equity (RoE) and earnings per share (EPS) of more than 20 per cent over the past five years. These blue chip stocks were picked from the primary universe of BSE 500 companies.

To ensure that these companies are able to meet their interest-payment obligations, we have tested them for adequate interest-coverage, and not-too-high debt-equity ratio.

Moreover, by limiting the price-earnings to growth (PEG) ratio at 1.5, we have tried to filter out the exorbitantly priced stocks from this list.

Upon running the above-mentioned filters, we got a list of seven stocks. All these belong to different sectors and are the leading entities in their segments.

GSK Consumer Healthcare: The company leads in the malted food beverage segment with brands such as Horlicks, Boost, Maltova and Viva. It continues to leverage on the strong brand equity of Horlicks and Boost by introducing value-added variants of these brands. The parent company, GlaxoSmithKline Plc. UK, has a strong and well-established product portfolio of various brands.

The company has over the past  few years put up a robust performance through sustained volume growth in its core brands and higher contributions from new product launches. It is a cash-rich company with a balance of Rs 820 crore as on December 2009.

Rising household incomes, increasing urbanisation, more hectic lifestyles, and growth in the number of working women are some of the factors that are expected to boost the demand for processed food products. The company is expected to maintain its recent pace of growth on account of a positive outlook for the food industry.

Larsen & Toubro: It is India's leading technology, engineering, construction and manufacturing company. The company also has manufacturing facilities in China, Oman and Saudi Arabia. Slowdown in the industrial and the real estate sectors in the second half of CY2009 adversely affected the revenue and profitability of the sector during the year.

To provide thrust to sluggish economic growth, the government is looking at boosting spending on infrastructure and simplifying the procedures for project approvals. L&T is likely to benefit from these government initiatives.

The company recently bagged an order for six laning of Krishnagiri-Walajahpet Highway from NHAI. It has also signed a joint venture with Howden to design, engineer, manufacture and supply axial fans and air pre-heaters to Indian thermal power plants of capacity ranging from 100 MW to 1,200 MW. These products are vital components of energy-efficient thermal power plants. The order book position of the company stood at Rs 70,300 crore at the end of FY09.

Marico: It is a leading group in the beauty and wellness space. The company occupies a leadership position with significant market shares in categories such as hair oil, post-wash hair care, anti-lice treatment, premium refined edible oil and niche fabric care. The company's branded products are present in  SAARC countries, West Asia, Egypt, Malaysia and South Africa.

In January 2010, Marico entered the South East Asian region through the acquisition of the hair styling brand Code 10 in Malaysia.

The company plans to focus on rural markets in order to achieve deeper penetration for its existing products and develop a basket of products more suited for these markets.

Maruti Suzuki: The company, which is a subsidiary of Suzuki Motor Corporation of Japan, is India's leading passenger car company, accounting for over 50 per cent of the domestic car market. It offers a full range of cars -- entry level Maruti 800 and Alto; mid-range cars such as the stylish hatchback Ritz, A star, Swift, Wagon R, and Estilo; sedans such as DZire and SX4; and sports utility vehicle Grand Vitara.

Financial year 2008-09 witnessed unprecedented fluctuations in the macroeconomic environment both globally and in India. However, the Indian economy was less affected and managed to grow well above 6 per cent. In FY10, however, the auto sector left behind its blues and put up a stellar performance, with Maruti Suzuki leading from the front.

The company has identified some key areas for action in the coming years, such as global procurement of high-technology components which are not available in India. Further, it plans to enhance the reliability of its supply chain, by focusing on industrial relations issues.

Piramal Healthcare: It is a healthcare company and is currently the fourth-largest in the Indian market with a diverse product portfolio spanning several therapeutic areas. It is also one of the largest custom-manufacturing companies with a global footprint of assets across North America, Europe and Asia.

In April 2010, the company acquired Bharat Serum & Vaccines' Anesthetic products' business consisting of Propofol, Bupivacaine and Atracurium Besylate. Recently, Piramal Healthcare sold its domestic formulation business to Illinois-based pharmaceuticals major Abbott.

Sesa Goa: The company is the country's leading private sector iron ore producer and exporter, with mining and processing facilities at various locations in India. It currently has access to 240 million metric tonne (MMT) reserves of iron ore. It is part of the Vedanta group's diversified global business interests in metals and mining industry with operations in India, Australia and Zambia.

Given the slowdown in the global economy, it is not surprising that the steel industry witnessed a sharp drop in demand during the second half of 2008-09. This led to a sharp reduction in steel production and hence contraction in demand for iron ore.

However, the company has a strong cash position and is actively exploring opportunities for acquiring mines to add to its resource base - both organically and inorganically - at a time when the depressed global economic scenario offers cost-effective opportunities.

Titan Industries: It is the world's fifth-largest integrated watch manufacturer. The company was formed as a joint venture between the Tata Group and Tamil Nadu Industrial Development Corporation. Its businesses include watches, jewellery, eyewear, and precision engineering.

In Q4FY10, the company registered healthy growth in volumes in the jewellery segment, despite high gold prices, pointing to a revival in consumer sentiments.

To avoid duplication of efforts in the retail area, the company has introduced the integrated retail services function. In the coming years considerable benefits are expected to accrue from the integration of retail services activities.

Take Your Pick
-Market Cap = Large or Mid
-Year EPS CAGR > 20%
-5 Year average ROE > 20%
-PEG <= 1.5
-5 Year Max ROE < 2 times 5 Year Min ROE
-Debt-Equity ratio < 2x
-Interest Coverage Ratio > 2x

Company Name		P/E		PEG ratio		DE ratio		ROE(%)		CAGR (%)		Price (Rs)
GSK Consumer Healthcare		30.79		1.36		0.00		24.98		22.67		1794.15
Larsen & Toubro		34.79		1.54		0.53		24.93		22.66		1825.55
Marico		32.60		1.25		0.84		41.67		26.01		128.40
Maruti Suzuki		16.30		0.68		0.08		20.81		23.81		1408.75
Piramal Healthcare		23.96		0.66		0.82		20.31		36.54		508.00
Sesa Goa		14.40		0.42		0.00		63.58		34.14		354.80
Titan Industries		43.72		1.36		0.32		30.72		32.12		2493.95
Price related data as on July 12, 2010; PEG - Price-Earning to growth; DE - Debt-Equity Ratio

View Profile

thanx

View Profile

Under current situation Very Bad..... Avoid this stock for now....... its Upside is Capped at 363 but donside if Breaks 320 then will fall to 300 /280 levels also...

Login to participate in discussion.

Disclaimer: The messages and ideas posted on this website are user's own views. Mudraa.com does not own any responsiblity for the information provided by the users.Data delayed 15 to 20 minutes unless otherwise indicated.